INTENSIVE INDUCTION THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) WHO EXPERIENCE A BONE MARROW RELAPSE

Trial Profile

INTENSIVE INDUCTION THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) WHO EXPERIENCE A BONE MARROW RELAPSE

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Oct 2013

At a glance

  • Drugs Imatinib (Primary) ; Asparaginase; Cyclophosphamide; Cytarabine; Cytarabine; Doxorubicin; Etoposide; Filgrastim; Folinic acid; Hydrocortisone; Methotrexate; Methotrexate; Pegaspargase; Prednisone; Vincristine
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Oct 2009 Additional trial identifier (COG-AALLOP12) and additional trial centres and investigators identified as reported by New Jersey Cancer Trial Connect record.
    • 05 Oct 2009 New source identified and integrated (New Jersey Cancer Trial Connect record no. COG-AALLOP12)
    • 20 Aug 2008 Results reported in the Journal of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top